Transplantable human thyroid organoids generated from embryonic stem cells to rescue hypothyroidism

Mírian Romitti, Adrien Tourneur, Barbara Faria da Fonseca, Gilles Doumont, Pierre Gillotay, Xiao-Hui Liao, Sema Elif Eski, Gaetan Simaeys, Laura Chomette, Helene Lasolle, Olivier Monestier, Dominika Figini Kasprzyk, Vincent Detours, Sumeet Pal Singh, Serge Goldman, Samuel Refetoff and Sabine Costagliola ()
Additional contact information
Mírian Romitti: Université Libre de Bruxelles (ULB)
Adrien Tourneur: Université Libre de Bruxelles (ULB)
Barbara Faria da Fonseca: Université Libre de Bruxelles (ULB)
Gilles Doumont: Université libre de Bruxelles (ULB)
Pierre Gillotay: Université Libre de Bruxelles (ULB)
Xiao-Hui Liao: The University of Chicago
Sema Elif Eski: Université Libre de Bruxelles (ULB)
Gaetan Simaeys: Université libre de Bruxelles (ULB)
Laura Chomette: Université Libre de Bruxelles (ULB)
Helene Lasolle: Université Libre de Bruxelles (ULB)
Olivier Monestier: Université Libre de Bruxelles (ULB)
Dominika Figini Kasprzyk: Université Libre de Bruxelles (ULB)
Vincent Detours: Université Libre de Bruxelles (ULB)
Sumeet Pal Singh: Université Libre de Bruxelles (ULB)
Serge Goldman: Université libre de Bruxelles (ULB)
Samuel Refetoff: The University of Chicago
Sabine Costagliola: Université Libre de Bruxelles (ULB)

Nature Communications, 2022, vol. 13, issue 1, 1-16

Abstract: Abstract The thyroid gland captures iodide in order to synthesize hormones that act on almost all tissues and are essential for normal growth and metabolism. Low plasma levels of thyroid hormones lead to hypothyroidism, which is one of the most common disorder in humans and is not always satisfactorily treated by lifelong hormone replacement. Therefore, in addition to the lack of in vitro tractable models to study human thyroid development, differentiation and maturation, functional human thyroid organoids could pave the way to explore new therapeutic approaches. Here we report the generation of transplantable thyroid organoids derived from human embryonic stem cells capable of restoring plasma thyroid hormone in athyreotic mice as a proof of concept for future therapeutic development.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-34776-7 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-34776-7

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-34776-7

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().